Literature DB >> 17596155

Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab.

E Sadler, B Schafleitner, C Lanschuetzer, M Laimer, G Pohla-Gubo, R Hametner, H Hintner, J W Bauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17596155     DOI： 10.1111/j.1365-2133.2007.08048.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  12 in total

Review 1.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 2.  Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen.

Authors:  Mei Chen; Gene H Kim; Lori Prakash; David T Woodley
Journal:  Autoimmunity       Date:  2011-09-28       Impact factor: 2.815

3.  Rituximab for autoimmune blistering diseases: recent studies, new insights.

Authors:  L Lunardon; A S Payne
Journal:  G Ital Dermatol Venereol       Date:  2012-06       Impact factor: 2.011

Review 4.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 5.  Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview.

Authors:  Kuan-Yu Chu; Hsin-Su Yu; Sebastian Yu
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

Review 6.  Rituximab in treatment-resistant autoimmune blistering skin disorders.

Authors:  Enno Schmidt; Eva-Bettina Bröcker; Matthias Goebeler
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

7.  Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.

Authors:  Ralf J Ludwig
Journal:  ISRN Dermatol       Date:  2013-07-15

Review 8.  Autoimmunity against type VII collagen in inflammatory bowel disease.

Authors:  Gheorghe Hundorfean; Markus F Neurath; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

Review 9.  Rituximab therapy in pemphigus and other autoantibody-mediated diseases.

Authors:  Nina A Ran; Aimee S Payne
Journal:  F1000Res       Date:  2017-01-27

10.  Shifting Focus in the Therapeutics of Immunobullous Disease.

Authors:  Abhishek De; Asad Ansari; Nidhi Sharma; Aarti Sarda
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.